Phylogica and Isogenica: Strategic alliance fast tracking screening of drug discovery targets
Phylogica scientists are now confident that using the display technology will ensure accelerated screening of the company’s vast Phylomer libraries to meet demand from potential pharmaceutical partners. Isogenica has been successful in hitting all milestones to date related to the collaboration, which was announced in January 2010.
The objectives of the project were to use Isogenica’s CIS display to achieve further optimisation of Phylogica’s lead compounds targeting CD40 ligand (CD40L).
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.